Clinical Trial Update: Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

View source ↗

Summary

This clinical trial update reports results from a completed study evaluating pegylated interferon alfa-2b (Peg-Intron) plus ribavirin (Rebetol) in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PEG Intron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Status: COMPLETED | Results posted: 2010-02-22